195 related articles for article (PubMed ID: 26010511)
21. Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells.
Cohen YZ; Lorenzi JCC; Seaman MS; Nogueira L; Schoofs T; Krassnig L; Butler A; Millard K; Fitzsimons T; Daniell X; Dizon JP; Shimeliovich I; Montefiori DC; Caskey M; Nussenzweig MC
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237833
[TBL] [Abstract][Full Text] [Related]
22. Live rubella vectors can express native HIV envelope glycoproteins targeted by broadly neutralizing antibodies and prime the immune response to an envelope protein boost.
Virnik K; Nesti E; Dail C; Scanlan A; Medvedev A; Vassell R; McGuire AT; Stamatatos L; Berkower I
Vaccine; 2018 Aug; 36(34):5166-5172. PubMed ID: 30037665
[TBL] [Abstract][Full Text] [Related]
23. Membrane bound Indian clade C HIV-1 envelope antigen induces antibodies to diverse and conserved epitopes upon DNA prime/protein boost in rabbits.
Rangasamy SP; Menon V; Dhopeshwarkar P; Pal R; Vaniambadi KS; Mahalingam S
Vaccine; 2016 May; 34(21):2444-2452. PubMed ID: 27032514
[TBL] [Abstract][Full Text] [Related]
24. Reconstitution and characterization of antibody repertoires of HIV-1-infected "elite neutralizers".
Sun Z; Li J; Hu X; Shao Y; Zhang MY
Antiviral Res; 2015 Jun; 118():1-9. PubMed ID: 25770672
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of envelope vaccines derived from the South African subtype C human immunodeficiency virus type 1 TV1 strain.
Lian Y; Srivastava I; Gómez-Román VR; Zur Megede J; Sun Y; Kan E; Hilt S; Engelbrecht S; Himathongkham S; Luciw PA; Otten G; Ulmer JB; Donnelly JJ; Rabussay D; Montefiori D; van Rensburg EJ; Barnett SW
J Virol; 2005 Nov; 79(21):13338-49. PubMed ID: 16227256
[TBL] [Abstract][Full Text] [Related]
26. Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins.
Kothe DL; Decker JM; Li Y; Weng Z; Bibollet-Ruche F; Zammit KP; Salazar MG; Chen Y; Salazar-Gonzalez JF; Moldoveanu Z; Mestecky J; Gao F; Haynes BF; Shaw GM; Muldoon M; Korber BT; Hahn BH
Virology; 2007 Mar; 360(1):218-34. PubMed ID: 17097711
[TBL] [Abstract][Full Text] [Related]
27. Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice.
Escolano A; Steichen JM; Dosenovic P; Kulp DW; Golijanin J; Sok D; Freund NT; Gitlin AD; Oliveira T; Araki T; Lowe S; Chen ST; Heinemann J; Yao KH; Georgeson E; Saye-Francisco KL; Gazumyan A; Adachi Y; Kubitz M; Burton DR; Schief WR; Nussenzweig MC
Cell; 2016 Sep; 166(6):1445-1458.e12. PubMed ID: 27610569
[TBL] [Abstract][Full Text] [Related]
28. Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies.
Verkoczy L; Alt FW; Tian M
Immunol Rev; 2017 Jan; 275(1):89-107. PubMed ID: 28133799
[TBL] [Abstract][Full Text] [Related]
29. Targeting broadly neutralizing antibody precursors: a naïve approach to vaccine design.
McGuire AT
Curr Opin HIV AIDS; 2019 Jul; 14(4):294-301. PubMed ID: 30946041
[TBL] [Abstract][Full Text] [Related]
30. Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models.
Saunders KO; Verkoczy LK; Jiang C; Zhang J; Parks R; Chen H; Housman M; Bouton-Verville H; Shen X; Trama AM; Scearce R; Sutherland L; Santra S; Newman A; Eaton A; Xu K; Georgiev IS; Joyce MG; Tomaras GD; Bonsignori M; Reed SG; Salazar A; Mascola JR; Moody MA; Cain DW; Centlivre M; Zurawski S; Zurawski G; Erickson HP; Kwong PD; Alam SM; Levy Y; Montefiori DC; Haynes BF
Cell Rep; 2017 Dec; 21(13):3681-3690. PubMed ID: 29281818
[TBL] [Abstract][Full Text] [Related]
31. Characterization of human IgG repertoires in an acute HIV-1 infection.
Chen W; Prabakaran P; Zhu Z; Feng Y; Streaker ED; Dimitrov DS
Exp Mol Pathol; 2012 Dec; 93(3):399-407. PubMed ID: 23036472
[TBL] [Abstract][Full Text] [Related]
32. B cell clonal lineage alterations upon recombinant HIV-1 envelope immunization of rhesus macaques.
Yacoob C; Lange MD; Cohen K; Lathia K; Feng J; Glenn J; Carbonetti S; Oliver B; Vigdorovich V; Sather DN; Stamatatos L
PLoS Pathog; 2018 Jun; 14(6):e1007120. PubMed ID: 29933399
[TBL] [Abstract][Full Text] [Related]
33. Standardized assessment of NAb responses elicited in rhesus monkeys immunized with single- or multi-clade HIV-1 envelope immunogens.
Seaman MS; Leblanc DF; Grandpre LE; Bartman MT; Montefiori DC; Letvin NL; Mascola JR
Virology; 2007 Oct; 367(1):175-86. PubMed ID: 17599382
[TBL] [Abstract][Full Text] [Related]
34. Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies.
Xiao X; Chen W; Feng Y; Dimitrov DS
Viruses; 2009 Dec; 1(3):802-17. PubMed ID: 21994570
[TBL] [Abstract][Full Text] [Related]
35. Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design.
Andrabi R; Voss JE; Liang CH; Briney B; McCoy LE; Wu CY; Wong CH; Poignard P; Burton DR
Immunity; 2015 Nov; 43(5):959-73. PubMed ID: 26588781
[TBL] [Abstract][Full Text] [Related]
36. Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans.
Zhang H; Fu H; Luallen RJ; Liu B; Lee FH; Doms RW; Geng Y
Vaccine; 2015 Sep; 33(39):5140-7. PubMed ID: 26277072
[TBL] [Abstract][Full Text] [Related]
37. Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.
Jiang X; Totrov M; Li W; Sampson JM; Williams C; Lu H; Wu X; Lu S; Wang S; Zolla-Pazner S; Kong XP
J Virol; 2016 Dec; 90(24):11007-11019. PubMed ID: 27707920
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of a novel neutralizing antibody targeting the CD4-binding site of HIV-1 gp120.
Qiao Y; Man L; Qiu Z; Yang L; Sun Y; He Y
Antiviral Res; 2016 Aug; 132():252-61. PubMed ID: 27387828
[TBL] [Abstract][Full Text] [Related]
39. Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization.
Sastry M; Changela A; Gorman J; Xu K; Chuang GY; Shen CH; Cheng C; Geng H; O'Dell S; Ou L; Rawi R; Reveiz M; Stewart-Jones GBE; Wang S; Zhang B; Zhou T; Biju A; Chambers M; Chen X; Corrigan AR; Lin BC; Louder MK; McKee K; Nazzari AF; Olia AS; Parchment DK; Sarfo EK; Stephens T; Stuckey J; Tsybovsky Y; Verardi R; Wang Y; Zheng CY; Chen Y; Doria-Rose NA; McDermott AB; Mascola JR; Kwong PD
J Virol; 2023 May; 97(5):e0160422. PubMed ID: 37098956
[TBL] [Abstract][Full Text] [Related]
40. Inducing cross-clade neutralizing antibodies against HIV-1 by immunofocusing.
Humbert M; Rasmussen RA; Ong H; Kaiser FM; Hu SL; Ruprecht RM
PLoS One; 2008; 3(12):e3937. PubMed ID: 19081789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
